$Inflammatory bowel disease and the risk of fracture$

Inflammatory bowel disease and the risk of fracture

Εμφάνιση άλλων εκδόσεων (3)

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	van Staa, T, Cooper, C, Probert, C, Leufkens, H, Javaid, M, Arden, N
Μορφή:	Conference item
Έκδοση:	2003

Παρόμοια τεκμήρια

INFLAMMATORY BOWEL DISEASE AND THE RISK OF FRACTURE
ανά: Arden, N, κ.ά.
Έκδοση: (2003)

Inflammatory bowel disease and the risk of fracture.
ανά: van Staa, T, κ.ά.
Έκδοση: (2003)

Inflammatory bowel disease and the risk of fracture
ανά: van Staa, T, κ.ά.
Έκδοση: (2002)

Use of nonsteroidal anti-inflammatory drugs and risk of fractures.
ανά: van Staa, T, κ.ά.
Έκδοση: (2000)

Inhaled corticosteroids and risk of fractures
ανά: Van Staa, T, κ.ά.
Έκδοση: (2000)

Use of inhaled corticosteroids and risk of fractures.
ανά: van Staa, T, κ.ά.
Έκδοση: (2001)

Inhaled corticosteroids and hip fracture: disease or drugs?
ανά: van Staa, T, κ.ά.
Έκδοση: (2003)

Children and the risk of fractures caused by oral corticosteroids.
ανά: van Staa, T, κ.ά.
Έκδοση: (2003)

Diseases and drugs associated with osteoporosis predict fractures at different sites
ανά: van Staa, T, κ.ά.
Έκδοση: (2001)

Utility of medical and drug history in fracture risk prediction among men and women.
ανά: van Staa, T, κ.ά.
Έκδοση: (2002)

Are inhaled corticosteroids associated with an increased risk of fracture in children?
ανά: van Staa, T, κ.ά.
Έκδοση: (2004)

The use of inhaled corticosteroids is not associated with an increased risk of fracture in children.
ανά: van Staa, T, κ.ά.
Έκδοση: (2001)

Osteoporosis in patients with inflammatory bowel disease.
ανά: Arden, N, κ.ά.
Έκδοση: (2002)

Does a fracture at one site predict later fractures at any other site?
ανά: van Staa, T, κ.ά.
Έκδοση: (2001)

Use of statins and risk of fractures.
ανά: van Staa, T, κ.ά.
Έκδοση: (2000)

Disease severity of asthma/copd and risk of osteoporotic fractures
ανά: de Vries, F, κ.ά.
Έκδοση: (2005)

Does a fracture at one site predict later fractures at other sites? A British cohort study.
ανά: van Staa, T, κ.ά.
Έκδοση: (2002)

Use of oral corticosteroids and risk of fractures.
ανά: Van Staa, T, κ.ά.
Έκδοση: (2000)

Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study.
ανά: de Vries, F, κ.ά.
Έκδοση: (2007)

Severity of obstructive airway disease and risk of osteoporotic fracture.
ανά: de Vries, F, κ.ά.
Έκδοση: (2005)

Use of statins and risk of fractures.
ανά: van Staa, T, κ.ά.
Έκδοση: (2001)

Statins and fracture risk - Reply
ανά: van Staa, T, κ.ά.
Έκδοση: (2001)

Use of oral corticosteroids and risk of fractures. June, 2000.
ανά: Van Staa, T, κ.ά.
Έκδοση: (2005)

Use of Thiazolidinediones and Risk of Osteoporotic Fracture: Disease or Drugs?
ανά: Bazelier, M, κ.ά.
Έκδοση: (2011)

Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?
ανά: Bazelier, M, κ.ά.
Έκδοση: (2012)

USE OF THIAZOLIDINEDIONES AND RISK OF OSTEOPOROTIC FRACTURE: DISEASE OR DRUGS?
ανά: Bazelier, M, κ.ά.
Έκδοση: (2010)

Oral corticosteroids and fracture risk: relationship to daily and cumulative doses.
ανά: van Staa, T, κ.ά.
Έκδοση: (2000)

Epidemiology of fractures in England and Wales.
ανά: van Staa, T, κ.ά.
Έκδοση: (2001)

The epidemiology of fractures in England and Wales
ανά: van Staa, T, κ.ά.
Έκδοση: (2001)

Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis.
ανά: van Staa, T, κ.ά.
Έκδοση: (2006)

Use of statins, risk of fracture and age-band bias
ανά: De Vries, F, κ.ά.
Έκδοση: (2006)

CUMULATIVE RISKS OF FRACTURE IN PATIENTS USING ORAL GLUCOCORTICOIDS
ανά: Van Staa, T, κ.ά.
Έκδοση: (2004)

KNEE ARTHOPLASTY AND RISK OF HIP FRACTURE: A POPULATION-BASED CASE-CONTROL STUDY
ανά: Lalmohamed, A, κ.ά.
Έκδοση: (2010)

Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands.
ανά: de Vries, F, κ.ά.
Έκδοση: (2007)

Use of beta-blockers and risk of hip and vertebral fracture: relationships to daily and cumulative dose
ανά: De Vries, F, κ.ά.
Έκδοση: (2006)

Fracture risk with intermittent high-dose oral glucocorticoid therapy.
ανά: De Vries, F, κ.ά.
Έκδοση: (2007)

Body mass index and bone mineral density by dexa in inflammatory bowel disease
ανά: Stroud, M, κ.ά.
Έκδοση: (2001)

The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results.
ανά: Van Staa, T, κ.ά.
Έκδοση: (2000)

Use of oral corticosteroids and risk of fractures (reprinted from JBMR, vol. 15, pg. 993-1000, yr. 2000)
ανά: Van Staa, T, κ.ά.
Έκδοση: (2005)

Use of beta-2 agonists and risk of hip fracture
ανά: De Vries, F, κ.ά.
Έκδοση: (2006)